In the present study, we showed that JARID1B was significantly overexpressed in NSCLC tumor samples and cell lines, and JARID1B overexpression correlated positively with tumor size, lymph node metastasis, advanced tumor stages (Fig. 2b), and poor overall survival in NSCLC patients (Fig. 2c). Here, KDM5B is linked to neoplasm.